LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin
Hits::

![]()
Institution:药学院
Title of Paper:LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin
Journal:《Invest New Drugs》
First Author:曲显俊
All the Authors:程艳娜,曲显俊
Document Code:lw-104094
Volume:29
Issue:12
Page Number:574
Number of Words:7000
Translation or Not:No
Date of Publication:2011-08
Release Time:2019-10-24